Genset sequences 'artherosclerosis' gene:
This article was originally published in Clinica
Executive Summary
European genomics company Genset has completely sequenced the genome of Chlamydia pneumoniae - a possible cause of coronary artery disease. By comparing the bacterium's genes with those of a related species, C trachomatis (also sequenced by Genset), the company hopes to show how C pneumoniae causes artherosclerotic lesions. Genset has filed patent applications for both sets of sequence data, which will be available for licensing by companies who want to develop diagnostic tests, vaccines and drugs.